Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neisseria meningitidis serogroup B polysaccharide capsule (None)
- Target
- None
- Molecular classification
- Polysaccharide, Capsular Polysaccharide
01
Overview
The polysaccharide capsule of *Neisseria meningitidis* serogroup B is a key virulence factor composed of α(2→8)-linked polysialic acid. It protects the bacterium from complement-mediated lysis and phagocytosis, enabling systemic invasion and disease. Its structural similarity to human neural cell adhesion molecules complicates vaccine development, necessitating protein-based vaccine strategies targeting other bacterial components.
- Other names
- Group B meningococcal capsuleSerogroup B capsulePoly(α2→8)-N-acetylneuraminic acid capsuleNmB capsule
02
Mechanism of action
Antibodies against the capsule or proteins associated with its production/presentation prevent or reduce bacterial survival and/or replication.
03
Biological functions
Immune evasionInhibition of complement-mediated killingProtection against phagocytosisVirulence factor
04
Disease associations
Invasive meningococcal diseaseBacterial meningitisSepticemia
05
Safety considerations
Molecular mimicry with human neural cell adhesion molecules poses challenges for vaccine development.Potential for autoimmunity due to structural similarity with host antigens.
Beyond the preview
Go deeper on Neisseria meningitidis serogroup B polysaccharide capsule (None).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neisseria meningitidis serogroup B polysaccharide capsule (None).